Hadeel Delman Najim, Mohammed Mahmood Mohammed, & Abbas Mahdi Rahmah. (2024). Influence of Adding Empagliflozin to Conventional Anti-diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences, 33(3), 142-149. https://doi.org/10.31351/vol33iss3pp142-149